Ann: Trading Halt, page-24

First 24 Last

Share
Profile

Follow
BackOnThe

3 Posts.

2

16/02/24

01:01

Post #: 72434254
Share

Originally posted by RooBendigo: ↑

My opinion:
I blame ASX' ham fisted intervention for the fact we are talking about this now. The ASX obligation on KIN would normally be to make an announcement when there was an implementation agreement, not when they are talking about talking about making an agreement, with no valuation figures and no case made by either party. I still can't believe someone in the ASX thought putting out feelers would have caused a SP bump, or that an ad hoc rule on disclosure was called for. . I am still cheesed off that investor interest more obviously attributable to the RIU booth was killed off for no good reason. I guess the value is still there and SP will recover, but still.

Delphi has about the same % of both companies, so Delphi can't lose if they merge whatever the valuation equation, and as KarlH says the NT project gets access to KIN's exploration funds.. The rest of us can lose, and I have zero interest in KIN's exploration focus shifting to the NT. In fairness to the board, if there was an agreement there would be a case put forward and maybe I would be persuaded. Not their fault I know we are talking about something not so much half baked as ingredients still in their packages.

A merger would not require KIN SH approval, but would require court approval, so a deal which rescued Delphi's NT investment at KIN's expense might not pass muster, but that is really a comment for if and when such a deal went beyond talking about talking about a deal.

Expand

Awful deal for old kin shareholders. Selling into more delphi control. Giving cash from kin. Absolutely no independence from kin directors.

KIN Price at posting: 6.5¢ Sentiment: Sell Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

There are more pages in this discussion • 7 more messages in this thread...

First 24 Last

Add PTN (ASX) to my watchlist

(20min delay)
Last 5.6¢		Change 0.002(3.70%)		Mkt cap ! $93.33M

Open	High	Low	Value	Volume
5.4¢	5.7¢	5.4¢	$45.01K	809.6K

Buyers (Bids)

No.	Vol.	Price($)
1	144087	5.5¢

Sellers (Offers)

Price($)	Vol.	No.
5.6¢	208538	1

View Market Depth

No.	Vol.	Price($)
1	144087	0.055
2	61770	0.054
1	18800	0.053
1	150000	0.052
4	312630	0.051

Price($)	Vol.	No.
0.056	208538	1
0.057	105618	3
0.058	194508	3
0.059	104738	4
0.060	669836	4

Last trade - 15.39pm 02/10/2024 (20 minute delay)

PTN (ASX) Chart

Ann: Trading Halt, page-24

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-24

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News